Blade Air Mobility Announces Date for Three Months and Calendar Year Ending December 31, 2021 Earnings Release Conference Call

Blade Air Mobility, Inc. (“Blade” or the “Company,” NASDAQ: BLDE) will release financial results for the three months and calendar year ended December 31, 2021 on Thursday, February 10, 2022, after the market closes. The company will hold a conference call the same day at 4:30 pm Eastern Time to discuss the results. The call will be hosted by Blade CEO Rob Wiesenthal and CFO Will Heyburn and will include a question-and-answer session for call participants.

On February 1, 2022, the Board of Directors of Blade acted to change the Company’s fiscal year from ending on September 30th to ending on December 31st. As a result, the three-months ended December 31, 2021 was a transition period and Blade’s financial results for the period from October 1, 2021 to December 31, 2021 will be filed on a Form 10-QT transition report. Blade’s current full fiscal year began on January 1, 2022 and will end on December 31, 2022. The Company’s fiscal quarters in 2022 will match calendar quarters.

Participants may access the call at 1-877-451-6152, international callers may use 1-201-389-0879, and request to join the Blade Urban Air Mobility earnings call. A live webcast will also be available by visiting the Investor Relations section of the company’s website at

A telephonic replay will be available shortly after the conclusion of the call and until February 24, 2022. Participants may access the replay at 1-844-512-2921, international callers may use 1-412-317-6671, and enter access code 13726792. An archived replay of the call will also be available on the Investors Relations section of the company’s website at

About Blade

Blade is a technology-powered, global air mobility platform committed to reducing travel friction by providing cost-effective air transportation alternatives to some of the most congested ground routes in the U.S. and abroad. Today, the Company predominantly uses helicopters and amphibious aircraft for its passenger routes and is also one of the largest air medical transporters of human organs for transplant in the world. Its asset-light model, coupled with its exclusive passenger terminal infrastructure, is designed to facilitate a seamless transition to Electric Vertical Aircraft (“EVA” or “eVTOL”), enabling lower cost air mobility to the public that is both quiet and emission-free.

For more information, visit


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.